The antibiotic resistance pattern of isolates was evaluated using the Kirby Bauer method according to the CLSI instructions against amikacin (AMK), clindamycin (CLI), ciprofloxacin (CIP), erythromycin (ERY), gentamicin (GEN), kanamycin (KAN), linezolid (LIN), penicillin (PEN), quinupristin-dalfopristin (SYN), rifampicin (RIF), tobramycin (TOB), tetracycline (TET),
teicoplanin (TEC), and
trimethoprim-sulfamethoxazole (SXT) (Mast Co., UK). MRSA strains were identified phenotypically using the Cefoxitin disk diffusion method (30
μg) according to the CLSI guidelines and detection of the
mecA gene as previously described [4 (
link)].
The microdilution was performed to determine minimum inhibitory concentration (MIC) titer for antibiotics vancomycin (VAN), tigecycline (TIG), and fusidic acid (FUS) according to the procedure detailed in our previous report [4 (
link)]. Results for fusidic acid and tigecycline were interpreted based on the European Committee for antimicrobial susceptibility testing (EUCAST) recommendations (
http://www.eucast.org). The inducible and constitutive macrolide-lincosamide-streptogramin group B (iMLS
B and cMLS
B) resistance phenotypes were identified by erythromycin and clindamycin disks by the CLSI guideline (CLSI 2019).
S. aureus ATCC 25923, ATCC 43300, and ATCC 29213 strains were used for antibiotic susceptibility testing quality control.
Zamani S., Mohammadi A., Hajikhani B., Abiri P., Fazeli M., Nasiri M.J., Dadashi M., Goudarzi M, & Haghighi M. (2022). Mupirocin-Resistant Staphylococcus aureus in Iran: A Biofilm Production and Genetic Characteristics. BioMed Research International, 2022, 7408029.